Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04843319
Title To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (VERU-100)
Acronym VERU-100
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Veru Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.